Login / Signup

Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis.

Peng HeJing LiMinyan ChenMeng HuangYibin QiuQindong CaiYuxiang LinChuan WangFangmeng Fu
Published in: Breast cancer research and treatment (2023)
Extended 10 year AI therapy may be optimal for HR + early breast cancer given its relatively high efficacy and safety.
Keyphrases
  • early breast cancer
  • systematic review
  • early stage
  • meta analyses
  • artificial intelligence
  • stem cells
  • case control
  • mesenchymal stem cells
  • bone marrow
  • smoking cessation
  • replacement therapy